{"status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved.", "response": {"docs": [{"word_count": "2808", "slideshow_credits": null, "multimedia": [{"type": "image", "subtype": "thumbnail", "width": 75, "height": 75, "url": "images/2012/04/03/us/sub03JPREGULATE1/sub03JPREGULATE1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/04/03/us/sub03JPREGULATE1/sub03JPREGULATE1-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}}], "news_desk": "National", "pub_date": "2012-04-03T00:00:00Z", "source": "The New York Times", "web_url": "http://www.nytimes.com/2012/04/03/health/policy/white-house-and-fda-at-odds-on-regulatory-issues.html", "blog": [], "_id": "515a5459fdc59278db00343c", "headline": {"content_kicker": "Political Science", "print_headline": "White House And the F.D.A. Often at Odds", "seo": "White House and F.D.A. at Odds on Regulatory Issues", "main": "White House and the F.D.A. Often at Odds"}, "subsection_name": "Money & Policy", "abstract": "Obama administration often disagrees with the Food and Drug Administration on regulatory issues, but FDA officials believe their decisions should be divorced from politics and based solely on their own scientific assessments; Republicans have relentlessly accused Obama of being an overzealous and job-killing regulator, forcing the administration to calibrate its election season positions (Series: Political Science).", "section_name": "Health", "byline": {"original": "By GARDINER HARRIS", "contributor": "", "person": [{"rank": 1, "firstname": "Gardiner", "lastname": "HARRIS", "role": "reported", "organization": ""}]}, "print_page": "1", "document_type": "article", "type_of_material": "News", "keywords": [{"rank": "1", "value": "Food and Drug Administration", "name": "organizations", "is_major": "Y"}, {"rank": "11", "value": "Series", "name": "subject", "is_major": "Y"}, {"rank": "2", "value": "Obama, Barack", "name": "persons", "is_major": "N"}, {"rank": "3", "value": "Sebelius, Kathleen", "name": "persons", "is_major": "N"}, {"rank": "4", "value": "United States Politics and Government", "name": "subject", "is_major": "N"}, {"rank": "5", "value": "Patient Protection and Affordable Care Act (2010)", "name": "subject", "is_major": "N"}, {"rank": "6", "value": "Regulation and Deregulation of Industry", "name": "subject", "is_major": "Y"}, {"rank": "7", "value": "DeParle, Nancy-Ann Min", "name": "persons", "is_major": "N"}, {"rank": "8", "value": "Hamburg, Margaret A", "name": "persons", "is_major": "N"}, {"rank": "9", "value": "Consumer Protection", "name": "subject", "is_major": "N"}, {"rank": "10", "value": "Law and Legislation", "name": "subject", "is_major": "N"}], "lead_paragraph": "Top officials with the Food and Drug Administration contend the agency\u2019s decisions should be divorced from politics and based solely on its own assessments of the science.", "snippet": "Top officials with the Food and Drug Administration contend the agency\u2019s decisions should be divorced from politics and based solely on its own assessments of the science."}], "meta": {"offset": 0, "hits": 1, "time": 23}}}